In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii
about
sameAs
Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosisQuinupristin-dalfopristin is active against Toxoplasma gondiiSynergistic effect of clindamycin and atovaquone in acute murine toxoplasmosisAtovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisTwo 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii.Rifabutin is active in murine models of toxoplasmosisNonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondiiTrovafloxacin is active against Toxoplasma gondiiIn vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondiiActivity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.Differential subcellular localization of members of the Toxoplasma gondii small heat shock protein familyActivity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compoundsToxoplasmosis, an overview with emphasis on ocular involvement.Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazineChemotherapy and immunity in opportunistic parasitic infections in AIDS.Human antiprotozoal therapy: past, present, and future.An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondiiTemporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivoNew paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections.Direct Effect of Two Naphthalene-Sulfonyl-Indole Compounds on Toxoplasma gondii TachyzoitePyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase.Antiparasitic treatment suppresses production and avidity of Toxoplasma gondii-specific antibodies in a murine model of acute infection*.Drugs in development for toxoplasmosis: advances, challenges, and current status.Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite.Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis.Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDSIn vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.Therapeutic progress. IV: Treatment and prophylaxis of Pneumocystis carinii infection.A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy.In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.Acute symptomatic toxoplasma retinochoroiditis.Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.Neurological and Neuropsychiatric Consequences of Chronic Toxoplasma Infection
P2860
Q24630917-A15E6CA4-FBCA-4578-9F61-1D1D6C23A08BQ28343473-92550CEE-A105-459B-95B0-72FCBCBA0511Q28343549-36233038-1C47-4E8B-942A-C24C17B376CAQ28365205-393E773D-C4DF-4233-8085-4AFBD584B744Q28368883-CDB80779-ECC8-490D-A28C-3F32DF54B40FQ28378281-F412FEB8-64F9-4F96-A836-E1942E041C9CQ28378795-7073A0D7-6254-4ACE-B352-E19FCE8D4945Q28379193-E6060646-5CDC-4386-BAC4-8B6BFC17E05BQ28379243-A0C170FF-9D77-4B40-A1FB-602B925B2F1FQ33745394-857E0624-E8AD-4AB3-9908-6352DC5AF8B4Q34232876-6E49B958-86CA-400F-8A5A-C40D070343D8Q34290022-F58A53DD-13CA-443D-AFCC-5C552F14DC64Q35014158-44C0DD0B-0B46-47AE-AB2A-3ED5D159D5DFQ35110989-6C5ED4B4-992E-4B05-B3A7-263CE591C7F3Q35224471-E21DCF6D-ABE7-4843-95D2-5ED02BDD75E1Q35535171-8AC6A5C3-A561-4548-9838-0B6D8082430CQ36028890-ADFB4842-8870-4203-A321-F6DBFB855A7BQ36804253-B032C033-96C4-47C0-B386-2C809D10C83FQ37093155-F4170870-B374-4E6F-810D-3358BD2FBE20Q37283682-8029BA84-49B7-45D5-8E8F-83F037A06997Q37287221-82129E51-67EF-4CDB-B835-F52FB028DC64Q37531268-40228C69-1E33-4C5D-93A4-975909BC55CAQ37613765-C17083FE-D4D3-4A7E-AEC3-3523ADC50D58Q38964632-B5FF56FF-0579-4FC1-91FB-3858A8F0E2F3Q39781573-378959AF-D2DF-4125-B4C5-E3C9A64CC91AQ39782411-FFDD5FF5-7746-491B-B895-809EF36CD2AEQ39882492-68758DEC-9F09-4FF7-81B0-A5C3CDFAB7D3Q40434099-016A23DA-DAA3-42E2-B935-0E7099002305Q40829190-2B3194D1-48B5-4333-A308-130462700F3DQ41831157-02F1DC88-8713-4566-A963-4DFC4DB495CDQ42554235-483F9677-AFC0-4C90-8E9A-67405BAF17B8Q44164523-88E4EA2F-FB1A-4D11-BCBD-5CFD7FE8312EQ44772323-A088FA56-84FB-4B2C-8720-18C1AFD3A721Q46050882-B28CE285-9D6B-4AD5-B153-26FF814B8EABQ56156856-CE0AF33A-59D3-4CE8-8E29-8871B92B49DF
P2860
In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@ast
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@en
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@nl
type
label
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@ast
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@en
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@nl
prefLabel
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@ast
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@en
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@nl
P2093
P2860
P3181
P356
P1476
In vitro and in vivo activitie ...... cyst form of Toxoplasma gondii
@en
P2093
F G Araujo
J Huskinson-Mark
J S Remington
W E Gutteridge
P2860
P304
P3181
P356
10.1128/AAC.36.2.326
P407
P577
1992-02-01T00:00:00Z